Dr. Reddy’s Mexico API plant gets two USFDA observations after records assessment - RDY News | RalliesDr. Reddy’s Mexico API plant gets two USFDA observations after records assessment
R
RDY• Company plans response
- Dr. Reddy's plans to respond to the two observations within the required timeline.
USFDA issues two observations after records assessment
- Dr. Reddy's Laboratories’ Dr. Reddy's Mexico API plant in Jiutepec, Mexico received two USFDA observations following a records assessment.
- The assessment under Section 704(a)(4) ran from July 17, 2026 to Sept. 8, 2026, and the USFDA issued Form FDA 2953.
•
